Updated:
Montreux Growth Partners
Founded in 1993, Montreux Equity Partners makes growth capital investments from its fifth fund in commercial-stage companies with $5 to $50 million in...
Montreux Growth Partners
Founded in 1993, Montreux Equity Partners makes growth capital investments from its fifth fund in commercial-stage companies with $5 to $50 million in revenues. It typically invests $10 to $20 million per company to support product expansion, new market entry, and strategic acquisitions. The portfolio addresses domestic and global trends in health through differentiated products, technologies, and services.
General information
Firm type
Private Equity
Year founded
1993
Location
Region
North America
Country
United States
City
San Francisco
Corporate office
Four Embarcadero Center, Suite 3720, San Francisco, CA 94111, United States
Sector focus
Frequently asked questions
Which sectors does Montreux Growth Partners exclusively focus on?
Montreux invests solely in healthcare and financial technology companies, as stated on its own public materials. Within healthcare, recent disclosed activity clusters around practice-management software and clinical-communication platforms, but the firm has not published a list of specific subsector exclusions. The FinTech side of the portfolio is less transparent from publicly available information.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: